Plainsboro, NJ, United States of America

Lan-Ying Qin

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Lan-Ying Qin

Introduction

Lan-Ying Qin is a prominent inventor based in Plainsboro, NJ (US), known for her significant contributions to the field of pharmaceutical sciences. With a total of 9 patents to her name, she has made remarkable advancements in the treatment of viral infections and proliferative disorders, including cancer.

Latest Patents

Among her latest patents, one notable invention is related to substituted phenyl oxazolone compounds. This patent discloses compounds of Formula (I) or their stereoisomers, tautomers, or salts, where each R is independently H or D. The invention also outlines methods for using these compounds to decrease the levels of IKZF1-4 proteins, which are crucial in the treatment of various viral infections and cancer. Another significant patent involves cyclic dinucleotides as anticancer agents. This invention is directed to compounds of the formula (I) and includes pharmaceutically acceptable compositions and methods for treating various disorders.

Career Highlights

Lan-Ying Qin is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. Her work focuses on developing innovative therapies that address critical health challenges.

Collaborations

Throughout her career, Lan-Ying has collaborated with esteemed colleagues, including Zheming Ruan and Brian E. Fink, to further enhance her research and development efforts.

Conclusion

Lan-Ying Qin's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a key inventor in advancing medical science. Her work continues to impact the treatment of serious health conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…